The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
The transcription factor Pax5 (BSAP) is required for the expression of a B-cell-specific genetic program and for B-cell differentiation, and also to suppress genes of alternative lineages. The molecular mechanism by which repression of myeloid genes occurs during early B-lineage restriction is unknown and in this study we addressed this question. One of the genes repressed by Pax5 in B cells is the colony-stimulating factor receptor 1 gene (csf1r or c-fms). We examined the changes in chromatin caused by Pax5 activity, and we show that Pax5 is directly recruited to c-fms resulting in the rapid loss of RNA polymerase II binding, followed by loss of transcription factor binding and DNaseI hypersensitivity at all cis-regulatory elements. We also show that Pax5 targets the basal transcription machinery of c-fms by interacting with a binding site within the major transcription start sites. Our results support a model by which Pax5 does not lead to major alterations in chromatin modification, but inhibits transcription by interfering with the action of myeloid transcription factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“RUNX1 physically interacts with PU.1, CEBPA, GATA1, GATA2, PAX5, FLI1, and ETS1.4–10,13”
From RUNX1 regulates corepressor interactions of PU.1 (2011) · cites this paper as [13]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“RUNX1 synergistically augments transcription activation by multiple hematopoietic lineage specifying transcription factors: PU.1, CEBPA, ETS1, GATA1, GATA2, FLI1, PAX5, SCL, and ERG”
From Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy (2014) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 1×
“…Biology Organization The EMBO Journal VOL 25 | NO 5 | 2006 1073 Repression of gene expression often involves the acquisition of inactive histone marks and the loss of active histone marks such as histone H3 lysine 4 methylation or lysine 9 acetylation, respectively (Jenuwein and Allis, 2001).”
BackgroundChen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages
Scott, E. W., Simon, M. C., Anastasi, J., & Singh, H. (1994) · Science · doi:10.1126/science.8079170 · Cited by 1,532 · cited 1×
“PU.1 is an essential factor regulating c-fms expression, and elimination of this factor abolishes c-fms expression and blocks macrophage differentiation (Scott et al, 1994; Simon et al, 1996).”
BackgroundMétivier, R., Penot, G., Hübner, M. R., Reid, G., Brand, H., Koš, M., & Gannon, F. (2003) · Cell · doi:10.1016/s0092-8674(03)00934-6 · Cited by 1,431
Dai, X.-M., Ryan, G. R., Hapel, A. J., Dominguez, M. G., Russell, R. G., Kapp, S., Sylvestre, V., & Stanley, E. R. (2002) · Blood · doi:10.1182/blood.v99.1.111 · Cited by 1,184
Commitment to the B-lymphoid lineage depends on the transcription factor Pax5
Nutt, S. L., Heavey, B., Rolink, A. G., & Busslinger, M. (1999) · Nature · doi:10.1038/44076 · Cited by 1,179
Self-citationStem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations
Weissman, I. L., Anderson, D. J., & Gage, F. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.387 · Cited by 948 · cited 1×
“All blood cells originate from hematopoietic stem cells (HSCs), which in the adult mammalian organism reside in the bone marrow and have the capacity to self-renew as well as differentiate (Weissman et al, 2001).”
BackgroundStepwise Reprogramming of B Cells into Macrophages
Xie, H., Ye, M., Feng, R., & Graf, T. (2004) · Cell · doi:10.1016/s0092-8674(04)00419-2 · Cited by 947 · cited 1×
“It has even been shown that the overexpression of myeloid-specific transcription factors in mature B cells can reprogram these cells into macrophages (Xie et al, 2004).”
BackgroundRegulation of B lymphocyte and macrophage development by graded expression of PU.1
DeKoter, R. P., & Singh, H. (2000) · Science · doi:10.1126/science.288.5470.1439 · Cited by 749 · cited 2×
“Overexpression of the transcription factor PU.1 in multipotent progenitor cells shifts differentiation toward myeloid cells (Nerlov and Graf, 1998; DeKoter and Singh, 2000; Yamada et al, 2001; McIvor et al, 2003).”
BackgroundURBANEK, P. (1994) · Cell · doi:10.1016/0092-8674(94)90079-5 · Cited by 670 · cited 1×
“Pax5 null cells in the bone marrow of knockout mice are blocked in B-cell differentiation (Urbánek et al, 1994; Nutt et al, 1997a; Hayashi et al, 2003), demonstrating that Pax5 is required for the activation of B-cellspecific genes (Nutt et al, 1998).”
BackgroundSasmono, R. T., Oceandy, D., Pollard, J. W., Tong, W., Pavli, P., Wainwright, B. J., Ostrowski, M. C., Himes, S. R., & Hume, D. A. (2003) · Blood · doi:10.1182/blood-2002-02-0569 · Cited by 662 · cited 1×
“The intronic elements, the c-fms intronic regulatory element (FIRE) and an upstream DHS (FIRE-1) are sufficient for the correct expression of c-fms in transgenic mice and stably transfected cells (Himes et al, 2001; Sasmono et al, 2003).”
BackgroundDiversification of haematopoietic stem cells to specific lineages
Orkin, S. H. (2000) · Nature Reviews Genetics · doi:10.1038/35049577 · Cited by 565 · cited 1×
“…shifting the balance of specific transcription factors in hematopoietic precursor cells dictates the outcome of cell differentiation (reviewed in Orkin, 2000; Graf, 2002) and this principle holds true for all differentiation decisions in all multicellular organisms that have been studied so far.”
BackgroundMurrell, A., Heeson, S., & Reik, W. (2004) · Nature Genetics · doi:10.1038/ng1402 · Cited by 556 · cited 1×
“However, it is known that interacting elements could co-precipitate after formaldehyde crosslinking (Murrell et al, 2004).”
BackgroundAdams, B., Dörfler, P., Aguzzi, A., Kozmik, Z., Urbánek, P., Maurer-Fogy, I., & Busslinger, M. (1992) · Genes & Development · doi:10.1101/gad.6.9.1589 · Cited by 525 · cited 1×
“…in 0.01% SDS, 1.1% Triton X-100, 1.2mM EDTA, 16.7mM Tris pH 8.0 and The EMBO Journal VOL 25 | NO 5 | 2006 &2006 European Molecular Biology Organization1078 167mM NaCl, and incubated overnight at 41C with an affinitypurified antibody (5mg) directed against the Pax5 paired domain (Adams et al, 1992).”
MethodInfluentialSelf-citationPU.1 induces myeloid lineage commitment in multipotent hematopoietic progenitors
Nerlov, C., & Graf, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2403 · Cited by 449 · cited 2×
“Overexpression of the transcription factor PU.1 in multipotent progenitor cells shifts differentiation toward myeloid cells (Nerlov and Graf, 1998; DeKoter and Singh, 2000; Yamada et al, 2001; McIvor et al, 2003).”
BackgroundKulessa, H., Frampton, J., & Graf, T. (1995) · Genes & Development · doi:10.1101/gad.9.10.1250 · Cited by 418 · cited 1×
“PU.1 functions in opposition to GATA-1, which regulates erythropoieses and inhibits GATA-1 activity (Kulessa et al, 1995; Nerlov et al, 2000; Zhang et al, 2000; Heyworth et al, 2002).”
BackgroundPax5 induces V -to- DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene
Fuxa, M., Skok, J., Souabni, A., Salvagiotto, G., Roldan, E., & Busslinger, M. (2004) · Genes & Development · doi:10.1101/gad.291504 · Cited by 414 · cited 1×
“Pro-B cells from the bone marrow of RAG2 / and RAG2 / Pax5 / mice (Fuxa et al, 2004) were grown for 5 days on ST2 cells in the presence of IL-7 (Nutt et al, 1997b) prior to crosslinking with 1% formaldehyde for 10min at room temperature.”
MethodSelf-citationNutt, S. L., Urbánek, P., Rolink, A., & Busslinger, M. (1997) · Genes & Development · doi:10.1101/gad.11.4.476 · Cited by 408 · cited 4×
“Differentiation of Pax5 / pro-B cells to macrophages was induced by removal of IL-7 from the culture and monocytic cells were transferred to fresh flasks at day 14 and cultured in IMDM, 10% FCS, 150mM monothioglycerol, P/S and 10% M-CSF containing L cell conditioned medium.”
BackgroundMethodInfluentialSelf-citationCzerny, T., Schaffner, G., & Busslinger, M. (1993) · Genes & Development · doi:10.1101/gad.7.10.2048 · Cited by 390 · cited 1×
“With its paired domain Pax5 makes extended and variable contacts to the DNA bases and phosphate backbone (Czerny et al, 1993; Garvie et al, 2001).”
BackgroundSelf-citationPU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding
Zhang, P., Zhang, X., Iwama, A., Yu, C., Smith, K. A., Mueller, B. U., Narravula, S., Torbett, B. E., Orkin, S. H., & Tenen, D. G. (2000) · Blood · doi:10.1182/blood.v96.8.2641 · Cited by 368 · cited 1×
“PU.1 functions in opposition to GATA-1, which regulates erythropoieses and inhibits GATA-1 activity (Kulessa et al, 1995; Nerlov et al, 2000; Zhang et al, 2000; Heyworth et al, 2002).”
BackgroundNerlov, C., Querfurth, E., Kulessa, H., & Graf, T. (2000) · Blood · doi:10.1182/blood.v95.8.2543 · Cited by 366 · cited 1×
“PU.1 functions in opposition to GATA-1, which regulates erythropoieses and inhibits GATA-1 activity (Kulessa et al, 1995; Nerlov et al, 2000; Zhang et al, 2000; Heyworth et al, 2002).”
BackgroundDifferentiation plasticity of hematopoietic cells
Graf, T. (2002) · Blood · doi:10.1182/blood.v99.9.3089 · Cited by 346 · cited 2×
“…shifting the balance of specific transcription factors in hematopoietic precursor cells dictates the outcome of cell differentiation (reviewed in Orkin, 2000; Graf, 2002) and this principle holds true for all differentiation decisions in all multicellular organisms that have been studied so far.”
BackgroundNutt, S. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2319 · Cited by 315 · cited 4×
“Pax5 null cells in the bone marrow of knockout mice are blocked in B-cell differentiation (Urbánek et al, 1994; Nutt et al, 1997a; Hayashi et al, 2003), demonstrating that Pax5 is required for the activation of B-cellspecific genes (Nutt et al, 1998).”
BackgroundMethodInfluentialSelf-citationHagemeier, C., Bannister, A. J., Cook, A., & Kouzarides, T. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1580 · Cited by 303 · cited 1×
“This is supported by biochemical experiments demonstrating that PU.1 can directly contact TFIID and this interaction requires the acidic activation domain of PU.1 (Hagemeier et al, 1993).”
MethodCzerny, T., & Busslinger, M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.5.2858 · Cited by 297 · cited 2×
“Our model is consistent with the previously determined Pax5 consensus binding sequence (Czerny and Busslinger, 1995) and shows the N- and C-terminal subdomains of the Pax5 paired domain binding in the major groove and the linker binding in an extended conformation in the minor groove of the c-fms…”
ResultSelf-citationReversion of B Cell Commitment upon Loss of Pax5 Expression
Mikkola, I., Heavey, B., Horcher, M., & Busslinger, M. (2002) · Science · doi:10.1126/science.1067518 · Cited by 291 · cited 3×
“This includes the colony-stimulating factor 1 receptor gene (csf1r or c-fms) or the myeloperoxidase gene (mpo), confirming that not only activators but also repressors are required for the establishment of a specific genetic program (Nutt et al, 1999; Mikkola et al, 2002; Tagoh et al, 2004b).”
BackgroundSelf-citationEberhard, D., Jiménez, G., Heavey, B., & Busslinger, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.10.2292 · Cited by 257 · cited 2×
“It interacts with the Groucho corepressor family member Grg4 to repress the activity of the immunoglobulin heavy chain enhancer (Eberhard et al, 2000; Linderson et al, 2004).”
BackgroundSelf-citationPax5 Promotes B Lymphopoiesis and Blocks T Cell Development by Repressing Notch1
Souabni, A., Cobaleda, C., Schebesta, M., & Busslinger, M. (2002) · Immunity · doi:10.1016/s1074-7613(02)00472-7 · Cited by 241
Self-citationStructural Studies of Ets-1/Pax5 Complex Formation on DNA
Garvie, C. W., Hagman, J., & Wolberger, C. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00410-5 · Cited by 200 · cited 3×
“With its paired domain Pax5 makes extended and variable contacts to the DNA bases and phosphate backbone (Czerny et al, 1993; Garvie et al, 2001).”
BackgroundMethodResultEnver, T., & Greaves, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81215-5 · Cited by 185 · cited 1×
“…made came from experiments demonstrating that HSCs express a lineage promiscuous gene expression program and that the chromatin of genes not yet expressed in precursor cells is already partially reorganized (Jimenez et al, 1992; Enver and Greaves, 1998; Kontaraki et al, 2000; Tagoh et al, 2004a).”
BackgroundActivation of the beta-globin locus control region precedes commitment to the erythroid lineage.
Jiménez, G., Griffiths, S. D., Ford, A. M., Greaves, M. F., & Enver, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10618 · Cited by 157 · cited 1×
“…made came from experiments demonstrating that HSCs express a lineage promiscuous gene expression program and that the chromatin of genes not yet expressed in precursor cells is already partially reorganized (Jimenez et al, 1992; Enver and Greaves, 1998; Kontaraki et al, 2000; Tagoh et al, 2004a).”
BackgroundHeyworth, C. M., Pearson, S., May, G. E., & Enver, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf368 · Cited by 143 · cited 1×
“PU.1 functions in opposition to GATA-1, which regulates erythropoieses and inhibits GATA-1 activity (Kulessa et al, 1995; Nerlov et al, 2000; Zhang et al, 2000; Heyworth et al, 2002).”
BackgroundChanges in frequencies of clonable pre B cells during life in different lymphoid organs of mice
Rolink, A., Haasner, D., Nishikawa, S., & Melchers, F. (1993) · Blood · doi:10.1182/blood.v81.9.2290.2290 · Cited by 136
Tagoh, H., Himes, R., Clarke, D., Leenen, P. J. M., Riggs, A. D., Hume, D., & Bonifer, C. (2002) · Genes & Development · doi:10.1101/gad.222002 · Cited by 123 · cited 3×
“Expression of this growth factor receptor is crucial for macrophage differentiation and is developmentally regulated (Dai et al, 2002; Tagoh et al, 2002). c-fms is a target of the transcription factor PU.1 and is already expressed at a low level in HSCs.”
BackgroundMethodSelf-citationKontaraki, J., Chen, H.-H., Riggs, A., & Bonifer, C. (2000) · Genes & Development · doi:10.1101/gad.14.16.2106 · Cited by 91 · cited 1×
“…made came from experiments demonstrating that HSCs express a lineage promiscuous gene expression program and that the chromatin of genes not yet expressed in precursor cells is already partially reorganized (Jimenez et al, 1992; Enver and Greaves, 1998; Kontaraki et al, 2000; Tagoh et al, 2004a).”
BackgroundSelf-citationHayashi, K., Yamamoto, M., Nojima, T., Goitsuka, R., & Kitamura, D. (2003) · Immunity · doi:10.1016/s1074-7613(03)00142-0 · Cited by 84 · cited 1×
“Pax5 null cells in the bone marrow of knockout mice are blocked in B-cell differentiation (Urbánek et al, 1994; Nutt et al, 1997a; Hayashi et al, 2003), demonstrating that Pax5 is required for the activation of B-cellspecific genes (Nutt et al, 1998).”
BackgroundRoss, I. L., Yue, X., Ostrowski, M. C., & Hume, D. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.12.6662 · Cited by 79 · cited 1×
“Pax5 destabilizes RNA polymerase II and interferes with PU.1 function The c-fms promoter belongs to the class of TATA-less promoters and instead contains clusters of PU.1/ets recognition sites that were shown to be sufficient for macrophage-specific transcription initiation (Ross et al, 1998).”
BackgroundA highly conserved c-fms gene intronic element controls macrophage-specific and regulated expression
Himes, S. R., Tagoh, H., Goonetilleke, N., Sasmono, T., Oceandy, D., Clark, R., Bonifer, C., & Hume, D. A. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.5.812 · Cited by 79 · cited 2×
“We have previously mapped three hypersensitive regions in the promoter and the first intron, which coincided with sequences highly conserved between human and mouse (Figure 1B) (Himes et al, 2001).”
BackgroundSelf-citationTagoh, H., Schebesta, A., Lefevre, P., Wilson, N. K., Hume, D. A., Busslinger, M., & Bonifer, C. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600421 · Cited by 77 · cited 17×
“…made came from experiments demonstrating that HSCs express a lineage promiscuous gene expression program and that the chromatin of genes not yet expressed in precursor cells is already partially reorganized (Jimenez et al, 1992; Enver and Greaves, 1998; Kontaraki et al, 2000; Tagoh et al, 2004a).”
BackgroundMethodResultInfluentialSelf-citationTagoh, H., Melnik, S., Lefevre, P., Chong, S., Riggs, A. D., & Bonifer, C. (2004) · Blood · doi:10.1182/blood-2003-09-3323 · Cited by 69 · cited 17×
“…made came from experiments demonstrating that HSCs express a lineage promiscuous gene expression program and that the chromatin of genes not yet expressed in precursor cells is already partially reorganized (Jimenez et al, 1992; Enver and Greaves, 1998; Kontaraki et al, 2000; Tagoh et al, 2004a).”
BackgroundMethodResultInfluentialSelf-citationLinderson, Y., Eberhard, D., Malin, S., Johansson, A., Busslinger, M., & Pettersson, S. (2004) · The EMBO Reports · doi:10.1038/sj.embor.7400089 · Cited by 64 · cited 2×
“It interacts with the Groucho corepressor family member Grg4 to repress the activity of the immunoglobulin heavy chain enhancer (Eberhard et al, 2000; Linderson et al, 2004).”
BackgroundSelf-citationBSAP Can Repress Enhancer Activity by Targeting PU.1 Function
Maitra, S., & Atchison, M. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.6.1911-1922.2000 · Cited by 64 · cited 1×
“In contrast to a previously published report (Maitra and Atchison, 2000), our data show that binding of Pax5 to DNA is required to repress c-fms promoter activity.”
ResultPax5 determines B- versus T-cell fate and does not block early myeloid-lineage development
Cotta, C. V., Zhang, Z., Kim, H.-G., & Klug, C. A. (2003) · Blood · doi:10.1182/blood-2002-10-3139 · Cited by 61 · cited 1×
“…|All Rights Reserved 0261-4189/06 www.embojournal.org The EMBO Journal VOL 25 | NO 5 | 2006 &2006 European Molecular Biology Organization EMBO THE JOURNAL 1070 et al, 2002; Cotta et al, 2003) and the molecular mechanism by which Pax5 represses myeloid-specific genes in B cells is not known.”
BackgroundMcIvor, Z., Hein, S., Fiegler, H., Schroeder, T., Stocking, C., Just, U., & Cross, M. A. (2003) · Experimental Hematology · doi:10.1016/s0301-472x(02)01017-2 · Cited by 58 · cited 1×
“Overexpression of the transcription factor PU.1 in multipotent progenitor cells shifts differentiation toward myeloid cells (Nerlov and Graf, 1998; DeKoter and Singh, 2000; Yamada et al, 2001; McIvor et al, 2003).”
BackgroundLefevre, P., Melnik, S., Wilson, N., Riggs, A. D., & Bonifer, C. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4386-4400.2003 · Cited by 49 · cited 1×
“Chromatin from cell lines was prepared as described (Lefevre et al, 2003) after crosslinking with 1% formaldehyde.”
MethodSelf-citationIdentification of DNaseI Hypersensitive Sites Within Nuclei
Cockerill, P. N. (2003) · Humana Press eBooks · doi:10.1385/1-59259-686-x:29 · Cited by 40 · cited 1×
“For DNaseI and MNase accessibility assay, cell nuclei were prepared as described by Cockerill (2000) after crosslinking with 1% formaldehyde for 5min and exposed to increasing amounts of DNaseI or MNase (Worthington).”
MethodTerminal Myeloid Gene Expression and Differentiation Requires the Transcription Factor PU.1
Simon, M. C., Olson, M. C., Scott, E., Hack, A. A., Su, G. H., & Singh, H. (1996) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-85232-9_11 · Cited by 36 · cited 1×
“PU.1 is an essential factor regulating c-fms expression, and elimination of this factor abolishes c-fms expression and blocks macrophage differentiation (Scott et al, 1994; Simon et al, 1996).”
BackgroundYamada, T., Abe, M., Higashi, T., Yamamoto, H., Kihara-Negishi, F., Sakurai, T., Shirai, T., & Oikawa, T. (2001) · Blood · doi:10.1182/blood.v97.8.2300 · Cited by 36 · cited 1×
“Overexpression of the transcription factor PU.1 in multipotent progenitor cells shifts differentiation toward myeloid cells (Nerlov and Graf, 1998; DeKoter and Singh, 2000; Yamada et al, 2001; McIvor et al, 2003).”
BackgroundIn Vivo Genomic Footprinting Using LM-PCR Methods
Tagoh, H., Cockerill, P. N., & Bonifer, C. (2006) · Humana Press eBooks · doi:10.1385/1-59745-005-7:285 · Cited by 26 · cited 6×
“In vivo DMS footprinting and LM-PCR were performed exactly as previously described (Tagoh et al, 2004b, 2006).”
MethodInfluentialSelf-citationFollows, G. A. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg804 · Cited by 18 · cited 1×
“…a ChIP assay showing that Pax5 induction results in a rapid reduction of RNA polymerase II binding to the c-fms promoter to the background levels observed in 3T3 cells, which we have shown not to express c-fms mRNA and not to bind RNA polymerase II and TATA-binding protein (Follows et al, 2003).”
Background
Research works printed but not linked: 1
- Nutt SL, Urba ´nek P, Rolink A, Busslinger M (1997b) Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. Genes Dev 11: 476-491 · DOI · Paper page
Cited by
CSF-1 receptor signaling in myeloid cells.
Stanley, E. R., & Chitu, V. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021857 · Cited by 825
“1D) (Tagoh et al. 2006; Bonifer and Hume 2008).”
Pax5: the guardian of B cell identity and function
Cobaleda, C., Schebesta, A., Delogu, A., & Busslinger, M. (2007) · Nature Immunology · doi:10.1038/ni1454 · Cited by 702
“Lastly, the characterization of Csf1r and Flt3 as direct Pax5 target genes indicated that Pax5 is able to mediate gene repression by binding to proximal promoter region”
BackgroundSelf-citationTranscriptional control of granulocyte and monocyte development
Friedman, A. D. (2007) · Oncogene · doi:10.1038/sj.onc.1210764 · Cited by 427
“Pax5 also represses the MCSFR promoter through direct interaction (Tagoh et al., 2006).”
BackgroundThe Transcriptional Regulation of B Cell Lineage Commitment
Nutt, S. L., & Kee, B. L. (2007) · Immunity · doi:10.1016/j.immuni.2007.05.010 · Cited by 387
Regulation of B cell fate commitment and immunoglobulin heavy-chain gene rearrangements by Ikaros
Reynaud, D., A Demarco, I., L Reddy, K., Schjerven, H., Bertolino, E., Chen, Z., Smale, S. T., Winandy, S., & Singh, H. (2008) · Nature Immunology · doi:10.1038/ni.1626 · Cited by 261
“Pax5 has been shown to target Csf1r , which encodes the receptor for macrophage colony-stimulating factor (M-CSF”
Background
Metadata
- Authors
- Tagoh, H., Ingram, R., Wilson, N., Salvagiotto, G., Warren, A. J., Clarke, D., Busslinger, M., & Bonifer, C.
- Affiliations
- University of Leeds (GB)
- Research Institute of Molecular Pathology (AT)
- MRC Laboratory of Molecular Biology (GB)
- Corresponding author
- Bonifer, Constanze
- Venue
- The EMBO Journal
- Published
- 2006-02-16
- Volume
- 25
- Issue
- 5
- Pages
- 1070-1080
- ISSN
- 0261-4189 (ISSN-L)
- 1460-2075
- PMC
- PMC1409732
- OpenAlex
- W2069029811
- Cited by
- 74
- References
- 50
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 1 · 2018: 2 · 2017: 1 · 2016: 2 · 2015: 1 · 2014: 7 · 2013: 5 · 2012: 6
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- The EMBO Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Kay Kendall Leukaemia Fund
- Directorate for Biological Sciences
- Medical Research Council
- Biotechnology and Biological Sciences Research Council
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- PAX5, c-fms, CSF1R, transcriptional repression, B cell differentiation, chromatin, DNase I hypersensitivity, RNA polymerase II binding, transcription start sites, cis-regulatory elements, transcription factor binding
- MeSH terms
- Proto-Oncogene Protein Spi-1, Animals, B-Lymphocytes, Chromatin, Deoxyribonuclease I, Gene Expression Regulation, Promoter Regions, Genetic, Protein Binding, Proto-Oncogene Proteins, Repressor Proteins, RNA Polymerase II, Transcription Factors, Transcription, Genetic, Trans-Activators, Receptor, Macrophage Colony-Stimulating Factor, Mice, Knockout, DNA Footprinting, Cell Lineage, Response Elements, Myeloid Cells, Transcription Initiation Site, Chromatin Immunoprecipitation, Mice, PAX5 Transcription Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.